A workshop was organized by the Agenzia Italiana del Farmaco (AIFA) to discuss unmet needs and ways forward in the development of medicines in heart failure, their rationale, and cost-effective use. An integrated, multidisciplinary approach, including patients' needs and perspectives, was advocated by all the participants as the way to the most effective treatment regimens. More work is needed for reaching consensus on clinical and functional endpoints, for validating patient reported outcomes and measurements of well-being. Similarly, the integration into the clinical programmes of the health technology assessment/payers perspective, in particular, the evaluation of 'real-life' treatment effectiveness and of health as a value, would help in shifting the development and authorization of medicines from the molecule paradigm to their evaluation in the context of the whole health care regimen. Through this kind of workshop, AIFA is trying to build a template for meetings devoted to debate unmet needs with all stakeholders towards tentative road maps for the future.

Steps forward in regulatory pathways for acute and chronic heart failure / Pani, Luca; Pecorelli, Sergio; Rosano, Giuseppe; Anker, Stefan D.; Peracino, Andrea; Fregonese, Laura; Prasad, Krishna; Rasi, Guido. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 17:1(2015), pp. 3-8. [10.1002/ejhf.209]

Steps forward in regulatory pathways for acute and chronic heart failure

Pani, Luca
Membro del Collaboration Group
;
2015

Abstract

A workshop was organized by the Agenzia Italiana del Farmaco (AIFA) to discuss unmet needs and ways forward in the development of medicines in heart failure, their rationale, and cost-effective use. An integrated, multidisciplinary approach, including patients' needs and perspectives, was advocated by all the participants as the way to the most effective treatment regimens. More work is needed for reaching consensus on clinical and functional endpoints, for validating patient reported outcomes and measurements of well-being. Similarly, the integration into the clinical programmes of the health technology assessment/payers perspective, in particular, the evaluation of 'real-life' treatment effectiveness and of health as a value, would help in shifting the development and authorization of medicines from the molecule paradigm to their evaluation in the context of the whole health care regimen. Through this kind of workshop, AIFA is trying to build a template for meetings devoted to debate unmet needs with all stakeholders towards tentative road maps for the future.
17
1
3
8
Steps forward in regulatory pathways for acute and chronic heart failure / Pani, Luca; Pecorelli, Sergio; Rosano, Giuseppe; Anker, Stefan D.; Peracino, Andrea; Fregonese, Laura; Prasad, Krishna; Rasi, Guido. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 17:1(2015), pp. 3-8. [10.1002/ejhf.209]
Pani, Luca; Pecorelli, Sergio; Rosano, Giuseppe; Anker, Stefan D.; Peracino, Andrea; Fregonese, Laura; Prasad, Krishna; Rasi, Guido
File in questo prodotto:
File Dimensione Formato  
Steps forward in regulatory pathways for acute and chronic heart failure..pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 211.79 kB
Formato Adobe PDF
211.79 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1175307
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact